Axillary reverse mapping: A prospective study in women with clinically node negative and node positive breast cancer

Annals of Surgical Oncology

Volumn 20, Issue 10, 2013, Pages 3303-3307

  Connor, Carol ^a   McGinness, Marilee ^a   Mammen, Joshua ^a   Ranallo, Lori ^b   Lafaver, Stephanie ^b   Klemp, Jennifer ^a   Fan, Fang ^a   Mahnken, Jonathan ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; ANATOMICAL VARIATION; ARTICLE; AXILLARY LYMPH NODE; AXILLARY REVERSE MAPPING; BREAST CANCER; CANCER SURGERY; FEMALE; HUMAN; INJECTION SITE NECROSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL METASTASIS; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM EXAMINATION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS;

AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHEDEMA; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 84883775639     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3113-4     Document Type: Article

References (10)

1. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst. 2006;98:599-609.
2. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102:111-8.
3. Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook K, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007;14:1890-5.
4. Boneti C, Korourian S, Diaz Z, Santiago C, Mumford S, Adkins L, et al. Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg. 2009;198:482-7.
5. Noguchi M, Noguchi M, Nakano Y, Ohno Y, Kosaka T. Axillary reverse mapping using a fluorescence imaging system in breast cancer. J Surg Oncol. 2012;105:229-34.
6. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer. 2010;116:2543-8.
7. Nos C, Kaufmann G, Clough KB, Collignon MA, Zerbib E, Cusumano P, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol. 2008;15:2550-5.
8. Gobardhan PD, Wijsman JH, Van Dalen T, Klompenhouwer EG, van der Schelling GP, Los J, Voogd AC, et al. ARM: axillary reverse - the need for selection of patients. Eur J Surg Oncol. 2012;38:657-67.
9. Casabona F, Bogliolo S, Menanda M, Sala P, Villa G, Ferrero S. Feasibility of axillary reverse mapping during sentinel node biopsy in breast cancer patients. Ann Surg Oncol. 2009;16:2459-63.
10. Giuliano AE, McCall L, Beitsche P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. Ann Surg. 2010;252:426-33.